Additional file 2: of Biobanking in Israel 2016–17; expressed perceptions versus real life enrollment

Updated consent form and additional information as used in real-life recruitment study. (DOCX 31 kb

Additional file 1: of Biobanking in Israel 2016–17; expressed perceptions versus real life enrollment

Original consent form, as presented to focus group participants. (DOCX 17 kb

Adjusted odds ratio and 95% confidence intervals of the associations of H. pylori infection, and gastric and duodenal ulcers, with diabetes mellitus by age (in years) and BMI (< and >25 kg/m2).

<p>Adjusted odds ratio and 95% confidence intervals of the associations of H. pylori infection, and gastric and duodenal ulcers, with diabetes mellitus by age (in years) and BMI (< and >25 kg/m2).</p

Prevalence of <i>H</i>. <i>pylori</i> infection (%) (urea breath test>3.5) by age group (in years) and country of birth; Maccabi Health Services, Israel 2002–2012.

<p>† Excluding countries that belonged to the Former Soviet Union.</p

Prevalence of diabetes mellitus according to <i>H</i>. <i>pylori</i> infection, and gastric and duodenal ulcers, by age group and BMI.

<p>Prevalence of diabetes mellitus according to <i>H</i>. <i>pylori</i> infection, and gastric and duodenal ulcers, by age group and BMI.</p

Age adjusted and age specific odds ratios and 95% confidence intervals of the associations of H. pylori infection, and gastric and duodenal ulcers, with diabetes mellitus, by age (in years) and BMI (< and >25 kg/m2).

<p>Age adjusted and age specific odds ratios and 95% confidence intervals of the associations of H. pylori infection, and gastric and duodenal ulcers, with diabetes mellitus, by age (in years) and BMI (< and >25 kg/m2).</p

<i>H</i>. <i>pylori</i> infection prevalence according to sociodemographic characteristics.

<p><i>H</i>. <i>pylori</i> infection prevalence according to sociodemographic characteristics.</p

Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-016-0169-8"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p> <p> </p> <p> </p

Study population characteristics, according to PDC with statins, patients eligible for the RA analysis (<i>n</i> = 211,627).

a<p>Kruskal-Wallis test for continuous data; χ² test for categorical data.</p>b<p>In the year prior to Index date.</p><p>GP, general practitioner; SD, standard deviation.</p

Mutually adjusted HRs and 95% CIs for OA according to PDC with statins and baseline characteristics, MHS 1998–2007.

a<p>Kruskal-Wallis test for continuous data; χ² test for categorical data.</p>b<p>In the year prior to Index date.</p><p>CVD, cardiovascular disease; GP, general practitioner.</p